Introduction And Aims: In 2009 Wilkinson and colleagues reported a downward trend in support for alcohol policy restrictions in Australia between 1995 and 2004. The aim of the current study is to examine more recent data on policy support in Australia, specifically for policies covering alcohol availability up to 2010, and to examine specific demographic shifts in support.
Design And Methods: Data was taken from the National Drug Strategy Household Surveys from 1995, 1998, 2001, 2004, 2007 and 2010 (n = 80,846), primarily responses to attitude items on policy restriction and demographic questions. The effects of age, sex, drinking patterns and income over time on three items addressing restriction of alcohol availability were assessed using a factorial analysis of variance.
Results: Although availability items are among the less popular policy restrictions put forward in the National Drug Strategy Household Surveys, 2004 actually represented a turning point in the decrease in popularity, with an increase in support since then. Though some groups show consistently higher rates of support than others for policy restrictions, the rate of change in support was fairly uniform across demographic and drinking groups.
Discussion And Conclusions: Despite the lack of an obvious catalyst, there has been an increase in support for alcohol policy restriction as it relates to general availability and accessibility since 2004. Furthermore, this increase does not appear to be a reflection of a change in a specific group of people, but appears to be occurring across the Australian population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/dar.12106 | DOI Listing |
Hepatol Commun
February 2025
Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Background: Alcohol-associated hepatitis (AH) leads to high rates of mortality and health care costs. Understanding the immediate costs after an AH diagnosis and identifying key cost factors is crucial for health care policies and clinical decisions.
Objectives: This study quantifies medical costs within 30 days of an AH diagnosis across outpatient (OP), emergency department (ED), and inpatient (IP) settings.
Cancer Med
February 2025
Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
Background: Male breast cancer (MBC) is rare and often treated using evidence from female breast cancer (BC) trials due to limited male participation. Previous estimates lacked global coverage and completeness. We aimed to quantify the global MBC burden from 1990 to 2021 and evaluate its current status and trends.
View Article and Find Full Text PDFCochrane Database Syst Rev
January 2025
Department of Health Promotion and Policy, University of Massachusetts, Amherst, MA, USA.
Background: Electronic cigarettes (ECs) are handheld electronic vaping devices that produce an aerosol by heating an e-liquid. People who smoke, healthcare providers, and regulators want to know if ECs can help people quit smoking, and if they are safe to use for this purpose. This is a review update conducted as part of a living systematic review.
View Article and Find Full Text PDFFront Public Health
January 2025
Department of Health Care Management, School of Information and Management, Guangxi Medical University, Nanning, Guangxi, China.
Background: The aging population presents a significant public health challenge, particularly concerning mental health and injury prevention. Anxiety and depression are common among the older adult, affecting their quality of life and increasing the risk of unintentional injuries (UI). This study aims to explore the association between anxiety and depression and UI risk among the older adult in Guangxi, China, using data from the 2023 National Health Service Survey.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!